Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 4
2006 1
2007 1
2008 1
2009 4
2010 7
2011 1
2012 1
2013 1
2015 6
2016 3
2017 6
2018 5
2019 4
2020 2
2021 6
2022 6
2023 5
2024 4
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team. Howard JF Jr, et al. Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
[Carpal tunnel syndrome].
Banach M, Gryz EA, Szczudlik A. Banach M, et al. Przegl Lek. 2004;61(2):120-5. Przegl Lek. 2004. PMID: 15230155 Review. Polish.
Role of RAGE in the Pathogenesis of Neurological Disorders.
Juranek J, Mukherjee K, Kordas B, Załęcki M, Korytko A, Zglejc-Waszak K, Szuszkiewicz J, Banach M. Juranek J, et al. Among authors: banach m. Neurosci Bull. 2022 Oct;38(10):1248-1262. doi: 10.1007/s12264-022-00878-x. Epub 2022 Jun 21. Neurosci Bull. 2022. PMID: 35729453 Free PMC article. Review.
Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label Study.
McAllister P, Patel AT, Banach M, Ellenbogen A, Slawek J, Paus S, Jinnah HA, Evidente V, Gross TM, Kazerooni R, Gallagher CJ, Hollander DA. McAllister P, et al. Among authors: banach m. Mov Disord Clin Pract. 2025 Nov;12(11):1764-1773. doi: 10.1002/mdc3.70104. Epub 2025 May 29. Mov Disord Clin Pract. 2025. PMID: 40439027 Free PMC article. Clinical Trial.
Efficacy and safety of DaxibotulinumtoxinA for injection in adults with cervical dystonia: Pooled global analysis of ASPEN-1 and ASPEN-1-CN randomized trials.
Ellenbogen A, Xingyue H, Lingjing J, Banach M, Patel AT, Gross TM, Kazerooni R, Gallagher CJ, Xiaojing F, Wang H, Lei G, Xinhua W, Hollander DA. Ellenbogen A, et al. Among authors: banach m. Parkinsonism Relat Disord. 2025 Nov;140:108015. doi: 10.1016/j.parkreldis.2025.108015. Epub 2025 Sep 2. Parkinsonism Relat Disord. 2025. PMID: 40961718 Free article. Clinical Trial.
Protocol and Demographics of the RELY-CD Study: Assessing Long-Term Clinical Response to Botulinum Neurotoxin in Cervical Dystonia.
Waeschle B, Lee JI, Kölsche T, Jansen R, Banach M, Ochudlo S, Tyślerowicz M, Sobolewski P, Sánchez Valiente S, López-Valdés E, Mir P, Jesús S, Ojeda-Lepe E, Papuć E, Sánchez Alonso P, Salazar G, Comes G, Stark H, Albrecht P. Waeschle B, et al. Among authors: banach m. Toxins (Basel). 2025 Apr 5;17(4):180. doi: 10.3390/toxins17040180. Toxins (Basel). 2025. PMID: 40278678 Free PMC article.
71 results